Medico Remedies Limited

NSE MEDICO.NS

Medico Remedies Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: 18.79%

Medico Remedies Limited Return on Capital Employed (ROCE) is 18.79% for the year ending March 31, 2024, a -20.44% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Medico Remedies Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 23.62%, a 27.12% change year over year.
Medico Remedies Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was 18.58%, a 51.87% change year over year.
Medico Remedies Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was 12.23%, a 258.62% change year over year.
Medico Remedies Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was 3.41%, a -44.75% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NSE: MEDICO.NS

Medico Remedies Limited

CEO	Mr. Haresh Kapurlal Mehta
IPO Date	May 26, 2022
Location	India
Headquarters	1105/1106, Hubtown Solaris
Employees	193
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Clinical Trials Fertilizers Pharmaceuticals

Description

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Key trends

Past 5 years